8 Matching Annotations
  1. Oct 2021
  2. Sep 2021
  3. Mar 2021
  4. Oct 2019
  5. Aug 2017
  6. Jul 2016
    1. Effective Copyright Policy: Copyrights encourage creativity and incentivize innovators to invest knowledge, time, and money into the generation of myriad forms of content. However, the copyright system has languished for many decades, and is in need of administrative reform to maximize its benefits in the digital age. Hillary believes the federal government should modernize the copyright system by unlocking—and facilitating access to—orphan works that languished unutilized, benefiting neither their creators nor the public. She will also promote open-licensing arrangements for copyrighted material and data supported by federal grant funding, including in education, science, and other fields. She will seek to develop technological infrastructure to support digitization, search, and repositories of such content, to facilitate its discoverability and use.   And she will encourage stakeholders to work together on creative solutions that remove barriers to the seamless and efficient licensing of content in the U.S. and abroad.

      "Effective Copyright Policy" section of "Hillary Clinton’s Initiative on Technology & Innovation". Note, especially, the position on orphan works.

  7. Jun 2016
    1. In rare cases, a questionable, published paper may acquire“orphan” status (Rennie & Flanagin, 1994, p. 469), as allconcerned try to wash their hands of it, invoking hyperlaborspecialization as grounds for exoneration. Such a scenario isinconceivable under the standard model, where authorshipand accountability are isomorphic. But when authorship/ownership of a study is distributed across multiple contrib-utors, many of whom may have zero or weak relation-ships—whether personal or institutional—with their myriadcoworkers (Katz & Martin, 1997), the practical (i.e., en-forceable) allocation of accountability may pose intractableproblems

      orphan papers: where everybody washes hand of poor results by saying it wasn't their specialisation. [[Why is this a problem, actually? The point is that we catch fraudulent or wrong papers, not that we have somebody to blame.

  8. May 2016
    1. that doesn't mean the drugs can't be immensely profitable. Treanda is an orphan drug but also Teva's second-best seller, racking up $740 million in sales last year, according to Teva's annual report.

      Isn't the whole point of an orphan drug classification that of limited commercial viability? So if they're not commercially viable how are they profitable?